相关实验视频
Updated: Sep 12, 2025

07:42
Nerve Excitability Assessment in Chemotherapy-induced Neurotoxicity
Published on: April 26, 2012
18.3K
拉科萨米德,普雷加巴林和塔潘塔多尔对外围神经刺激性的影响:一项随机,双盲,安慰剂控制,交叉,多中心临床试验,在健康受试者中进行
Zahra Nochi1, Hossein Pia2, Petra Bloms-Funke3
1Danish Pain Research Center, Department of Clinical Medicine, Aarhus University, Aarhus, Denmark. Assistant professor, z.nochi@clin.au.dk.
Anesthesiology
|August 4, 2025
概括
拉科萨米德在健康人群中显著降低了周围神经刺激能力,特别影响了大型感觉和运动纤维. 这一发现突出了神经刺激性测试作为一种检测药物对神经功能影响的方法.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 临床试验 临床试验
背景情况:
- 慢性疼痛是一个全球性的健康问题,有效治疗方法有限,副作用频繁.
- 该IMI-PainCare-BioPain项目试图标准化生物标志物,以改善止痛药的开发.
- 这项研究 (IMI2-PainCare-BioPain-RCT1) 调查了特定止痛药对外围神经刺激性的影响.
研究的目的:
- 为了评估lacosamide,pregabalin和tapentadol对健康个体外围神经刺激性的影响.
- 通过神经刺激性测试来评估这些药物的药理学影响.
- 确定神经兴奋度的测量是否可以作为止痛药效应的生物标志物.
主要方法:
- 这是一项随机,双盲,安慰剂控制的交叉试验,涉及43名健康参与者 (年龄在18-45岁).
- 参与者在四个时间段中接受了单剂量的lacosamide (200 mg),pregabalin (150 mg),tapentadol (100 mg) 或安慰剂.
- 主要终点侧重于大感觉和运动纤维的强度持续时间常数 (SDTC) 的变化;其他措施包括恢复周期和值电度.
主要成果:
- 与安慰剂相比,乳胺显著降低了大型感觉和运动纤维中的SDTC (分别p=0.012和p=0.039).
- 对于普雷加巴林或塔潘塔多尔,没有观察到对SDTC的显著影响.
- 拉科萨米德还诱导了大型感觉纤维的低兴奋度和值电度参数的显著变化.
结论:
- 神经刺激性测试可以有效地检测药物对健康人群中大髓质神经纤维的药理学影响.
- 拉科萨米德显著降低了周围神经刺激能力,特别是影响大感觉纤维.
- 这些发现支持神经兴奋度测量在开发新型止痛疗法的实用性.
相关概念视频
Local Anesthetics: Differential Sensitivity of Nerve Fibers
933
Local anesthetics (LAs) block the sodium channels of nerve trunks, sensory nerve endings, and neuromuscular junctions. Although LAs can block all kinds of nerves, the sensitivity of nerve fibers differs according to nerve types and structures. LAs are known to block myelinated fibers faster than unmyelinated ones. Also, they block pain or sensory neurons at low concentrations without affecting the motor neurons involved in muscle contractions. This helps relieve labor pain without affecting the...
933
Antiepileptic Drugs: GABAergic Pathway Potentiators
650
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
650
Antiepileptic Drugs: Glutamate Antagonists
516
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
516
Antiepileptic Drugs: Potassium Channel Activators
278
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
278

